Low Tristetraprolin Expression Activates Phenotypic Plasticity and Primes Transition to Lethal Prostate Cancer in Mice

Scientists reported that that loss of tristetraprolin (TTP) increased NF-κB activation, and was associated with higher rates of aggressive disease and early recurrence in primary prostate cancer.